Founded in 2013, Dongsheng Chiral Pharmaceuticals Technology Co., Ltd. (Former Shanghai Yaocheng Pharmaceutical Co., Ltd.), located in the Lin-gang Special Area of Shanghai Pilot Free Trade Zone, is a Contract Development Manufacture Organization (CDMO) enterprise focusing on the R&D and production of new drugs. At present, a small molecule drugs process R&D center has been operated in Wujiang District, Suzhou, while a production base for key intermediates of Class I innovative drugs has been put into operation in Lanzhou New Area, Gansu Province, and a high-level R & D center has been built in the Western Medicine Valley of Lanzhou. The Company focuses on the development of high technical barriers, difficulty and complex chiral pharmaceutical API and intermediate products, and explores innovative synthesis pathways by comprehensive use of asymmetric catalysis, chiral induction, enzyme catalysis, salting-out crystallization and other technologies to greatly optimize the production process of new pharmaceutical intermediates. It provides innovative pharmaceutical companies with one-stop services for the whole cycle of new pharmaceutical research and development, process optimization, test site and commercial customized production.

With the core values of “adhering to innovation, striving for perfection, surviving by quality, moving with altruism”, Dongsheng Chiral rises abruptly based on its accumulated strength as always. Pursuing the vision of “devoting to building high-quality innovation pharmaceutical service platform”, Dongsheng Chiral provides assistance to innovative pharmaceutical companies, reduces the R&D cost of new drugs, and delivers high-quality new drugs to every patient in need at an affordable price, which contributes its technical strength to human health.